Biogen, AbbVie once-monthly MS injection wins U.S. FDA approval
The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc.
The self-administered, under-the-skin injection, Zinbryta, is designed to treat adults with relapsing forms of the disease.
source : Reuters
29 – May – 2016